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313 Health-related quality of life in Russia: Data on the CFQ-R in
children with cystic ﬁbrosis
Y. Gorinova1, A.L. Quittner2, O. Simonova1. 1Scientiﬁc Center of Children’s
Health, RAMS, Department of Pulmonology and Allergology, Moscow, Russian
Federation; 2University of Miami, Departments of Psychology and Pediatrics,
Coral Gables, United States
Objectives: Cystic Fibrosis (CF) is a chronic, progressive and life-shortening
disease. Life expectancy has increased substantially in recent decades due to early
diagnosis and improved treatment. Health-related quality of life (HRQOL) measures
are patient-centered and provide information about the patient’s own assessment of
his respiratory symptoms, physical, social, and emotional functioning and well-
being.
Methods: 40 children with CF completed the age-appropriate Russian version of
the CFQ-R. Forced expiratory volume in 1 second (FEV1% predicted), body mass
index (BMI) and intravenous antibiotic treatment (IV) were utilized as measures of
health status.
Conclusion: On average, scaled scores on the CFQ-R were as follows: Physical
Functioning (70.9±25.5), Emotional Functioning (72.2±15.6), Eating Disturbances
(69.7±25.7), Treatment Burden (74.4±18), Social Functioning (63.7±17.7), Body
Image (82.7±21.6), Respiratory Symptoms (67.7±25.7) and Digestive Symptoms
(72.5±24.9). Intraclass correlation coefﬁcients measuring parent–child agreement
ranged from r = 0.47 to 0.74 (p’s <0.001), indicating very good agreement. Sig-
niﬁcant associations were also found between lung function and CFQ-R Physical
Functioning (r = 0.36, p = 0.02) and Respiratory Symptoms (r = 0.55, p = 0.000). No
associations were found between BMI and CFQ-R scales. A trend was also found
between number of IV courses and CFQ-R Physical Functioning (r = −0.43, but
p = 0.07).
This pilot study of the Russian version of the CFQ-R demonstrated strong con-
vergent validity. This Russian translation of the CFQ-R can be used to evaluate
HRQOL in children with CF, including use in drug trials and observational studies.
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Objectives: Economic evaluations of new treatments are measured in terms of
quality-adjusted life years (QALYs). QALYs require utility data (e.g. EQ-5D data)
which is often not collected in clinical trials. The Cystic Fibrosis Questionnaire-
Revised (CFQ-R) is a well validated and utilised CF patient reported outcome
measure. This study aimed to develop a mapping algorithm to estimate EQ-5D
utility values from the CFQ-R.
Methods: Adults with Cystic Fibrosis (CF) were recruited by the CF Trust
in the UK to complete an online survey including the CFQ-R, EQ-5D and a
clinical/demographic form. Statistical mapping between the CFQ-R and EQ-5D
was estimated using three different methods: ordinary least square (OLS) regression,
Tobit, and Two-Part Models (TPM). Items, domains, squared terms and covariates
were considered. All models were assessed using goodness of ﬁt and model
predictive performance statistics.
Conclusion: 401 CF patients participated (61% females), age 18−26 yrs, with a
broad range of lung function compromise (mild − severe). All 3 regression methods
performed well using both domain level and item level models: OLS (root mean
square error [RMSE] = 0.174 and 0.171), TPM (RMSE = 0.127 and 0.096), and
Tobit (RMSE = 0.173 and 0.136). The best performing model was the item level
TPM, including age and gender covariates with a difference of 0.008 between
observed (0.671) and predicted (0.679) EQ-5D scores.
This study provides mapping algorithms strongly correlating CFQ-R to the EQ-5D.
These algorithms can be used to estimate utility values from CFQ-R scores for
economic analysis in datasets without a preference based measure.
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Introduction: Disease speciﬁc tools exist for assessing the quality of life (QoL)
of People with Cystic Fibrosis (PWCF) with no global measure that captures the
overall balance from various QoL spheres. We present a single QoL score based
on a latent trait model.
Methods: Responses from the Cystic Fibrosis Questionnaire (CFQ-R) collected in
2007 were analysed. These were grouped into the 12 domains and transformed into
percentages with higher values indicating better QoL in the domain. The scores were
then dichotomized at the median and a one parameter Rasch model ﬁt to estimate a
single value considered the overall measure of QoL. This measure depends on the
individual performance in each domain considering its difﬁculty and on how other
respondents performed and ranges between −6 and +6 with higher positive scores
showing better overall QoL.
Results: Among the 248 PWCF (5.3–55.5 years), 51.0% were males with 63.0%
aged 18 or over. The highest scores, mean±SD, were in the digestive symptoms
(75.1±22.1) domain while the lowest were in social functioning (53.8±23.1). On
the new scale, the easiest and most difﬁcult items were in weight problems and
social functioning with difﬁculty parameters −1.16 and +1.25 respectively. The
overall QoL score had values between −1.65 and 2.47 with mean±SD of 0.4±1.0.
Conclusions: It is difﬁcult to compare individuals or make an overall assessment
of QoL using several percentages. The single score is easy to interpret and utilizes
more information. It gives a single quantitative measure and simpliﬁes longitudinal
assessment even with some missing data.
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Objective: This study examined the generic and CF-speciﬁc QOL in CF children
using a tool based on a modular clinical approach.
Method: Sample consisted of 12 CF children and 12 healthy children aged 8 to
12 years, matched by age and sex. The Quality of Life Systemic Inventory for
Children (QLSI-C) assess both generic (20 items) and CF-speciﬁc (6 items) QOL.
CF-speciﬁc module is empirically created from CFQ-R and discussion with medical
staff. QLSI-C is a dynamic tool, using a VAS, which considers QOL (gap) like the
difference between the present situation (state) and the expectations (goal). This
difference is weighted by the importance (rank) that children assign for each life
domains. QLSI-C is different from PedQoL, which consider QOL like an assessment
of state score only.
Results: Difference between CF and healthy children for the QOL score approached
signiﬁcance (F = 3.63; p = 0.07). Results by items show a signiﬁcant difference
for “autonomy” (F = 4.30; p = 0.05) and “frustration tolerance” (F = 4.60; p = 0.04)
between the two groups. In addition, global scores in CF-speciﬁc module is
correlated with global score in generic module for CF children (r = 0.66 to 0.96).
Assessment of QOL is the same for both generic (M= 3.76) and CF-speciﬁc
(M= 3.76) module (p = 0.53). Finally, descriptive statistics demonstrate that items
which reﬂect the best QOL in CF children were based on social support unlike
healthy children.
Conclusion: QLSI-C is a clinical tool which distinguishes between children with CF
and healthy children. Originality of this tool is strengthened by the consideration of
individual life plan taking into account the particular situation of children with CF.
